文献速递中医内科中药与中成药合理使用

高血压合并失眠的发病机制与中药干预治疗潜力

Pathogenesis and therapeutic potential of traditional Chinese medicine intervention in hypertension combined with insomnia.
PubMed 文献 · J Ethnopharmacol · 2026-07-15

该综述检索近五年文献,总结中药单体、复方及中成药治疗高血压合并失眠(HTN-Ins)的机制与疗效。中药通过抑制交感神经过度激活、抗炎、抗氧化、调节RAAS与HPA轴及神经递质等多靶点途径发挥镇静催眠、稳降血压和血管保护作用,但单体机制与复方大样本RCT仍需深入。

要点

  • 天麻、钩藤、川芎、丹参、黄芪等中药及天麻钩藤饮等复方常用于HTN-Ins。
  • 中药多靶点调控交感神经、炎症、氧化应激、RAAS、HPA轴和神经递质。
  • 现有证据以机制探讨为主,复方大样本多中心RCT仍缺乏。

核心结论

  • 中药通过多靶点、多途径、多层次及个体化策略治疗HTN-Ins具有显著疗效和潜力。
  • 未来需深入探究中药单体药理机制并开展复方大样本多中心RCT。

研究设计与样本

  • 检索PubMed、Web of Science和CNKI近五年至2026年4月发表的研究,检索词包括traditional Chinese medicine、hypertension and insomnia等。

主要发现

  • 常用中药包括天麻、钩藤、川芎、丹参和黄芪。
  • 有益的中药单体包括槲皮素、山奈酚、木犀草素和黄芩素。
  • 常用复方包括天麻钩藤饮、黄连温胆汤、桂枝龙骨牡蛎汤等。
  • 中成药包括冠心宁片、复方珍珠调脂胶囊、芪参益气滴丸、舒和颗粒等。
  • 机制涉及抑制交感神经过度激活、降低炎症因子、减轻氧化应激、调节RAAS、HPA轴及神经递质水平。

临床怎么用

  • 临床可基于辨证选用天麻、钩藤、川芎、丹参、黄芪及天麻钩藤饮等复方治疗HTN-Ins。
  • 中药通过镇静催眠、稳降血压和血管保护等多重药理作用改善HTN-Ins。

局限性

  • 中药单体的药理机制尚需深入探究。
  • 中药复方缺乏大样本、多中心随机对照临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNIC PHARMACOLOGICAL RELEVANCE: Hypertension comorbid with insomnia (HTN-Ins) is a common clinical comorbidity. Symptoms associated with HTN-Ins correspond to the TCM disease categories of xuanyun (dizziness), xinji (palpitations), and bumei (insomnia). Traditional Chinese medicine (TCM) exerts unique therapeutic advantages against HTN-Ins via regulating the body's dynamic imbalance. AIM OF THIS REVIEW: This review aims to summarize the characteristics of TCM for treating HTN-Ins, including single Chinese herbs, Chinese medicine monomers, compound TCM prescriptions, TCM patented drugs, and other TCM-related therapeutic approaches, focusing on the analysis of the relevant mechanisms of TCM treatment of this disease. METHODS: Using the search terms "traditional Chinese medicine", "hypertension and insomnia", "hypertension combined with insomnia", "hypertension", "insomnia", "sleep disorder", "mechanism", "clinical observation", "randomized controlled trial", we searched PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) for studies published in the past five years up to April 2026. RESULTS: From the literature review, we found that Chinese herbs such as Gastrodia elata Blume., Uncaria rhynchophylla (Miq.) Miq., Conioselinum anthriscoides 'Chuanxiong'., Salvia miltiorrhiza Bunge and Astragalus mongholicus Bunge were commonly used for the treatment of HTN-Ins. Traditional Chinese medicine monomers such as quercetin, kaempferol, luteolin|, baicalein are beneficial for the treatment of HTN-Ins. A large number of traditional Chinese medicine compounds have significant effects, including Tianma-Gouteng decoction, Huanglian-Wendan decoction, Guizhilonggu-oyster decoction, etc. In recent years, traditional Chinese patent medicine has been used in the treatment of HTN-Ins, such as Guanxin Ning tablets, compound pearl Tiaozhi capsules, Qishen Yiqi dropping pills, Shuhe granules, and so on. Research has also shown that TCM works in a variety of ways, including the inhibiting excessive activation of the sympathetic nervous system, reducing the levels of relevant inflammatory factors, alleviating oxidative stress, regulating the renin-angiotensin-aldosterone system (RAAS), regulating the hypothalamic-pituitary-adrenal (HPA) axis, and regulating neurotransmitter levels. These actions collectively produce comprehensive pharmacological effects, such as sedative-hypnotic activity, stable blood pressure reduction, and vascular protection. CONCLUSIONS: TCM exhibits remarkable therapeutic efficacy in the treatment of HTN-Ins through multi-target, multi-pathway, multi-level, and individualized strategies, thereby demonstrating substantial therapeutic potential. However, limitations remain. In the future, in-depth exploration of the pharmacological mechanisms underlying individual TCM monomers and large-sample, multi-center randomized controlled clinical trials (RCTs) of TCM compound prescriptions will be the primary research directions in this field.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Ning B, He L, et al. Pathogenesis and therapeutic potential of traditional Chinese medicine intervention in hypertension combined with insomnia. J Ethnopharmacol. 2026. PMID: 42456906. doi:10.1016/j.jep.2026.122186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。